MIRA INFORM REPORT
|
Report Date : |
07.01.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
DR. REDDY’S LABORATORIES LTD. BEIJING
REPRESENTATIVE OFFICE |
|
|
|
|
Registered Office : |
Room 2305, Block A, Oriental Media Center, No. 4 Courtyard, Guanghua
Road, Chaoyang District, Beijing, 100026 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Date of Incorporation : |
18.06.2010 |
|
|
|
|
Com. Reg. No.: |
110000450140778 |
|
|
|
|
Legal Form : |
Representative Office |
|
|
|
|
Line of Business : |
business consulting service for its parent company. |
|
|
|
|
No. of Employees
: |
5 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Representative office |
|
|
|
|
Payment
Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
DR.
REDDY’S LABORATORIES LTD. beijing Representative office
ROOM 2305, BLOCK A, ORIENTAL MEDIA CENTER, NO. 4
courtyard, guanghua road, CHAOYANG DISTRICT, BEIJING, 100026 PR CHINA
TEL: 86 (0) 10-85597629/85597633 FAX: 86 (0) 10-85597634
EXECUTIVE SUMMARY
INCORPORATION DATE : june
18, 2010
REGISTRATION NO. : 110000450140778
REGISTERED LEGAL FORM : Representative office
STAFF STRENGTH :
5
REGISTERED CAPITAL : n/a
BUSINESS LINE : liaison
TURNOVER :
n/a
EQUITIES :
n/a
PAYMENT :
not yet determined
RECOMM. CREDIT RANGE : c.o.d.
MARKET CONDITION : FAIR
FINANCIAL CONDITION : n/a
OPERATIONAL TREND : FAIRLY steady
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.31
= USD 1
Adopted abbreviations
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
CNY - China Yuan Renminbi
SC was registered as a representative office at local
Administration for Industry & Commerce (AIC - The official body of issuing
and renewing business license) on June 18, 2010.
Company Status: Representative office Foreign company, which has
entered into a contract with a PR China co., is permitted to establish a
representative office in PR China. The representative office may engage
only in “non-direct operating activities” such as liaison, consulting,
market research & general information gathering. At present,
representative office is not allowed to employ local employees in its own
name and must use PR China employment agencies.
SC’s registered
business scope includes engaging in non-profit business activities which
related to the foreign (region) enterprise attached.
SC is mainly
engaged in business consulting service for its parent company.
Mr. Satheeshkumar
is the principal of SC at present.
SC is known to have
approx. 5 employees at present.
SC is
currently operating at the above stated address, and this address houses its
operating office in the commercial zone of Beijing. Detailed premise
information is not available at present.
http://www.drreddys.com/ The
website belongs to SC’s parent company. The design is professional and the
content is well organized. At present the web site is only in English version.
E-Mail: satheeshkumar@drreddyschina.com
No significant events or changes were found during our checks with the
local Administration for Industry & Commerce.
PARENT COMPANY:
Name
Dr. Reddy's Laboratories Limited (India)
Add: Door No
Tel: +91-40-49002900
Fax: +91-40-49002999
Web: www.drreddys.com
l
Principal:
Mr. Satheeshkumar, Indian, he is currently responsible for the overall
management of SC.
Working Experience(s):
At present Working
in SC as principal.
SC is mainly engaged
in business consulting service for its parent company.
SC’s parent company is mainly engaged in
providing affordable and innovative medicines for healthier lives.
According
to the above website:
Dr. Reddy’S Laboratories Ltd. Shanghai Representative Office
Principal: Cherala Venkat Narayan Rao
Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
Etc.
Overall payment appraisal:
( ) Excellent (
) Good ( ) Average
( ) Fair (
) Poor (X) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience: N/A
Delinquent
payment record: None in our database.
Debt collection record: No overdue amount owed by SC was placed to us for
collection within the last 6 years.
The bank
information is not available in local AIC.
As a representative office, SC is not allowed to engage in direct business.
All its expenses are supposed to be provided by its parent company. Therefore,
its financial information is not available.
SC is a representative office, which is not engaged in direct business. Credit
dealings with SC are recommended under secured terms at present, while C.O.D.
is recommended.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.78 |
|
UK Pound |
1 |
Rs.81.79 |
|
Euro |
1 |
Rs.67.46 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.